💡 Company approved preferential allotment of warrants to raise ~₹99 Cr for growth.

What Happened

Vikas Lifecare Limited's Fund-Raising Committee has approved the preferential allotment of up to 61.9 crore fully convertible warrants at an issue price of ₹1.60 per warrant. This move aims to raise an aggregate amount of up to ₹99.05 crore from a mix of promoter group and public category investors. The approval follows a board decision to raise funds not exceeding ₹200 crore.

Key Details

Why It Matters

This significant capital infusion of nearly ₹100 crore strengthens the company's balance sheet and provides funds for potential expansion, working capital, or strategic initiatives. The issue price of ₹1.60 per warrant is notably higher than the regulatory floor price, indicating investor confidence. The capital raise is subject to shareholder and regulatory approvals, but it represents a major step in the company's financial planning.

Disclaimer: This is publicly available information sourced from NSE. Not investment advice.

Get signals like this instantly

Free Telegram alerts within 2 minutes of NSE filing

Join SuperStock Free
← Back to all analysis